These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22371774)

  • 21. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
    Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
    Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome.
    Ho SL; Dogar GF; Wang J; Crean J; Wu QD; Oliver N; Weitz S; Murray A; Cleary PE; O'Brien C
    Br J Ophthalmol; 2005 Feb; 89(2):169-73. PubMed ID: 15665347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deranged Metabolic Profile and Identification of Biomarkers in the Vitreous Humour of Patients with Proliferative Diabetic Retinopathy.
    Sahajpal NS; Vig VK; Singh R; Singh H; Chaubey A; Singh K; Goel RK; Jain SK
    Protein Pept Lett; 2018; 25(8):791-798. PubMed ID: 30129402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of expression profiling of circular RNAs in vitreous humour between diabetic retinopathy and non-diabetes mellitus patients.
    He M; Wang W; Yu H; Wang D; Cao D; Zeng Y; Wu Q; Zhong P; Cheng Z; Hu Y; Zhang L
    Acta Diabetol; 2020 Apr; 57(4):479-489. PubMed ID: 31749049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative retinopathy during hyperbaric oxygen treatment.
    Tran V; Smart D
    Diving Hyperb Med; 2017 Sep; 47(3):203. PubMed ID: 28868603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Alam K; Nawaz MI; Mohammad G; Van den Eynde K; Siddiquei MM; Mousa A; De Hertogh G; Opdenakker G
    Curr Eye Res; 2016 Dec; 41(12):1590-1600. PubMed ID: 27261371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.
    Van Geest RJ; Klaassen I; Lesnik-Oberstein SY; Tan HS; Mura M; Goldschmeding R; Van Noorden CJ; Schlingemann RO
    J Cell Commun Signal; 2013 Mar; 7(1):1-9. PubMed ID: 23054594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
    Jacqueminet S; Ben Abdesselam O; Chapman MJ; Nicolay N; Foglietti MJ; Grimaldi A; Beaudeux JL
    Clin Chim Acta; 2006 May; 367(1-2):103-7. PubMed ID: 16426593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy.
    Salzmann J; Limb GA; Khaw PT; Gregor ZJ; Webster L; Chignell AH; Charteris DG
    Br J Ophthalmol; 2000 Oct; 84(10):1091-6. PubMed ID: 11004090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
    Tashimo A; Mitamura Y; Nagai S; Nakamura Y; Ohtsuka K; Mizue Y; Nishihira J
    Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Level of vascular endothelial growth factor and interleukin-6 in aqueous humor in diabetic retinopathy patients].
    Zhou L; Sun H; Xu J; Kang J
    Yan Ke Xue Bao; 2010 Aug; 25(1):26-30. PubMed ID: 21166036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
    Tuuminen R; Sahanne S; Loukovaara S
    Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible involvement of nitric oxide in the progression of diabetic retinopathy.
    Tsai DC; Chiou SH; Lee FL; Chou CK; Chen SJ; Peng CH; Kuo YH; Chen CF; Ho LL; Hsu WM
    Ophthalmologica; 2003; 217(5):342-6. PubMed ID: 12913324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and aqueous levels of alarin and adipsin ın patients with and without diabetic retinopathy.
    Gül FC; Kobat SG; Çelik F; Aydin S; Akkoç RF
    BMC Ophthalmol; 2022 Apr; 22(1):176. PubMed ID: 35436912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy.
    Kwon SH; Shin JP; Kim IT; Park DH
    Ophthalmology; 2015 May; 122(5):968-75. PubMed ID: 25687026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of matrix metalloproteinase 9 and its tissue inhibitor 1 in development and prognosis of diabetic retinopathy.
    Ziablitsev SV; Korobova AV; Petrenko OV; Serduk VN; Mogilevsky SU
    Fiziol Zh (1994); 2016; 62(5):37-44. PubMed ID: 30204340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring intraocular antibodies in eyes treated with anti-vascular endothelial growth factor.
    Rullo J; Bae S; Far PM; Hazimi AA; Gupta V; Bal M; Hopman WM; Irrcher I; Urton T; Bona M; Campbell R; Gonder T; Sharma S
    Can J Ophthalmol; 2020 Jun; 55(3):263-271. PubMed ID: 32253011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular imaging system for possible prediction of active retinopathy in patients with Diabetes mellitus.
    Golubnitschaja O; Jaksche A; Moenkemann H; Yeghiazaryan K; Karl SE; Trog D; Schild HH; Löffler KU
    Amino Acids; 2005 Mar; 28(2):229-37. PubMed ID: 15723238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy.
    Beránek M; Kolar P; Tschoplova S; Kankova K; Vasku A
    Mol Vis; 2008 Jun; 14():1114-21. PubMed ID: 18552985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.